Irinotecan, Capecitabine

TERMINATED · PHASE2 · Colorectal Neoplasms, Secondary, Drug Therapy, Combination

The study drugs are not covered anymore by insurance.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.